158 results on '"Purdy, J.A."'
Search Results
2. The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated)
3. Long-Term Results of NRG Oncology/RTOG 0321 A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate
4. The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521
5. Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer
6. COMPILATION AND EVALUATION OF RADIATION DEPTH DOSE DATA FROM ELECTRON ACCELERATORS USED FOR RADIOTHERAPY: EXPERIENCES OF A PILOT DATA PROJECT IN A HOSPITAL ENVIRONMENT
7. Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)
8. Dose–Volume Modeling of Brachial Plexus-Associated Neuropathy After Radiation Therapy for Head-and-Neck Cancer: Findings From a Prospective Screening Protocol
9. Quantification of Gross Tumor Volume Changes Between Simulation and First Day of Radiation Therapy for Patients With Locally Advanced Malignancies of the Lung and Head/Neck
10. Differences in Clinical Outcome Among Patients Treated by Intensity Modulated Radiation Therapy With and Without Image Guidance for Head-and-Neck Cancer
11. Differential Response Rates In Vivo to Irradiation among Patients with Human Papillomavirus Positive and Negative Oropharyngeal Cancer
12. Comparison of Brachial Plexus Dosimetry using Extended-field and Split-field Techniques in the Management of Head and Neck Cancer with Intensity Modulated Radiotherapy
13. Failure Mode and Effect Analysis for Stereotactic Body Radiation Therapy Delivery
14. Evaluation of Hippocampal Dose for Patients Undergoing Intensity Modulated Radiotherapy for Nasopharyngeal Cancer
15. Dosimetric Evaluation Of Less-than-daily IGRT Regimens In The Treatment Of Nasopharyngeal Carcinoma
16. Voice Quality after Organ-Preservation Therapy for Laryngeal Cancer
17. Prospective Clinical-dosimetric Evaluation of Normal Tissue Tolerance of the Brachial Plexus among Patients treated by Intensity Modulated Radiotherapy for Head and Neck Cancer
18. Relationship between Pelvic Organ at Risk Dose and Clinical Target Volume in Post-prostatectomy Patients Receiving Intensity Modulated Radiation Therapy
19. Potential Utility of Image-guidance to Reduce PTV Margins for Patients Treated by IMRT for Head and Neck Cancer: Evaluation of Temporal-based Protocols
20. Prospective Study to Determine Ideal Dose Constraints for the Oral Cavity in Patients Undergoing Intensity Modulated Radiotherapy for Head and Neck Cancer
21. Changes in Position and Volume of Lung Cancer Target Volumes during Stereotactic Body Radiotherapy (SBRT): Is Image Guidance Necessary?
22. Is Daily Image-guided Radiotherapy (IGRT) Really Necessary in the Treatment of Head and Neck Cancer with Intensity-modulated Radiotherapy (IMRT)?
23. A Phase II Comparative Study of Gross Tumor Volume Definition with or without PET/CT Fusion in Dosimetric Planning for Non–small-cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515
24. Mathematical Modeling of Dose Volume Histograms (DVHs) among Patients undergoing Radiation Therapy for Prostate Cancer
25. Validating the RTOG-endorsed Brachial Plexus Contouring Atlas: An Evaluation of Reproducibility
26. Daily MVCT to Evaluate the True Delivered Dose to the Spinal Cord, Mandible, and Parotid Glands during the Head and Neck Cancer Radiotherapy
27. Dosimetric Analysis of the Brachial Plexus among Patients Treated by Post-mastectomy Radiation Therapy for Breast Cancer
28. An Electronic Phantom for Testing and Quality Assurance of Dose Volume Histogram Calculations used in Data Analysis for Multi Institutional Clinical Trials
29. Clinical-dosimetric Analysis of Lacrimal Gland Dysfunction among Patients Treated by Intensity-modulated Radiotherapy for Sinonasal Tumors
30. Multi-system Verification of Registrations Utilized in IGRT Processes
31. Primary Radiation Therapy for Carcinomas of the Paranasal Sinus and Nasal Cavity using IMRT
32. Long-term Single Institutional Experience with the Use of Daily Image-guided Radiotherapy (IGRT) for the Treatment of Head and Neck Cancer
33. Brachial Plexopathy after Radiation Therapy for Head-and-Neck Cancer
34. Image Guidance is Most Critical in the First Two Weeks for Patients Treated by Radiation Therapy for Head and Neck Cancer: Implications for Adaptive Radiotherapy
35. Clinical-dosimetric Analysis of Measures of Dysphagia in Head and Neck Cancer Patients Treated by Concurrent Chemoradiation with Definitive Intent
36. Impact of Protocol Complexity on Digital Data Integrity Quality Assurance for Clinical Trials Requiring Digital Data Submission
37. Head and Neck Cancer among Lifelong Never Smokers and Ever Smokers: Matched-pair Analysis of Outcomes after Radiation Therapy
38. The Effect of Heterogeneity Correction on Stereotactic Body Radiation Therapy (SBRT) Treatment Planning for Lung Cancer
39. Vector Analysis of Patient Setup with Image Guided Radiation Therapy (IGRT) via Kv Cone Beam CT (CBCT)
40. Unplanned Interruptions during Radiation Therapy for Head and Neck Cancer: Analysis of Potential Pretreatment Risk Factors for Non-compliance
41. Comparison of Daily versus Less-than-daily Image-guided Radiotherapy Protocols in the Treatment of Head and Neck Cancer
42. A Survey of the ITC Volumetric Treatment Planning Data Archive Supporting RTOG Advanced Technology Clinical Trials
43. Change of Rectal Volume Over the Course of IMRT Prostate Cancer Treatment Observed With CBCT
44. 2737
45. 1011
46. 2407
47. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level V
48. Errors in radiation oncology: a study in pathways and dosimetric impact
49. Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer
50. Toxicity following 3D radiation therapy for prostate cancer on RTOG 9406 dose level IV
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.